As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist,...
weight-loss
Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—most...
Weight loss drugs are changing the economic picture from many angles. In addition to reshaping the healthcare, retail, and leisure...
Weight-loss drugs are becoming a popular employee perk, with almost a third of workers saying they’d switch jobs to get...
David Protein CEO: GLP-1 drugs killed diet trends—and is making the future of food harder to predict
Every January, David Protein founder and CEO Peter Rahal knew what to expect: the emergence of a new diet trend...
Gill Baird: back on a strong financial footing Cosmedicare, the private healthcare provider, is set to post record profits after...